Table of Contents
Who is the CEO of GlaxoSmithKline?
Emma Walmsley (Apr 2017–)
GlaxoSmithKline/CEO
GlaxoSmithKline Chief Executive Officer Emma Walmsley faces renewed calls for her ouster after Bluebell Capital Partners has taken a £10 million (about $13.7 million) stake in the company.
What is GlaxoSmithKline famous for?
GlaxoSmithKline (GSK) is a manufacturing giant known for popular prescription medications, vaccines, and consumer health products. Well-known prescription medications include products such as antidepressant, Paxil and antidiabetic, Avandia, along with dozens of other drugs including: Imitrex (sumatriptan)
When was GlaxoSmithKline founded?
December 2000
GlaxoSmithKline/Founded
Who is Emma Walmsley husband?
David Owenm. 1995
Emma Walmsley/Husband
What is Walmsley salary?
Soriot’s rival Emma Walmsley, boss of British drugs giant Glaxosmithkline, was the FTSE 100’s best-paid female chief executive last year. The 52-year-old’s £7m package included a £1.2m salary, £245,000 in pension contributions and £5.4m in bonuses.
How much does Emma Walmsley make?
As the Chief Executive Officer and Executive Director of GlaxoSmithKline Plc, the total compensation of Emma Walmsley at GlaxoSmithKline Plc is GBX8,369,000. There are no executives at GlaxoSmithKline Plc getting paid more.
Is GSK an Indian company?
GlaxoSmithKline Pharmaceuticals Ltd (BSE: 500660 NSE: GSKCONS) is an Indian subsidiary of GlaxoSmithKline plc, one of the world’s leading research based pharmaceutical and healthcare companies. It is one of the oldest pharmaceuticals companies in India.
Is GSK American?
GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in London, England.
When did Walmsley join GSK?
May 2010
She joined GlaxoSmithKline in May 2010 as President of Consumer Healthcare Europe, rising in October 2011 to head its global consumer healthcare division as President of Consumer Healthcare Worldwide and a member of the executive team. In March 2015 she became the chief executive officer of Consumer Healthcare.
How much is GSK net worth?
The estimated Net Worth of Plc Glaxosmithkline is at least $934 Million dollars as of 24 July 2020. Plc Glaxosmithkline owns over 1,260,504 units of Pandion Therapeutics stock worth over $277,814,659 and over the last 17 years Plc sold PAND stock worth over $656,033,715.
Is Emma Walmsley leaving GSK?
GlaxoSmithKline isn’t just making changes with its U.S. operations. The adjustment marks another step forward for GSK CEO Emma Walmsley’s plan to split up the firm into two separate U.K.-listed healthcare giants, one focused on consumer health and the remaining “new GSK” focused on pharmaceuticals and vaccines.